close

Text Messaging for Heart Failure Medication Adherence

Heart failure is a long-term condition in which the heart cannot pump effectively enough to meet the body’s needs. People commonly take several medicines to control symptoms, protect the heart and prevent deterioration. A feasibility study of a text message intervention for medication adherence in heart failure examines whether a simple reminder and support programme is practical, acceptable and safe enough to test more broadly.

Rather than asking immediately whether texts improve clinical outcomes, the study concentrates on delivery: can patients receive and use them, can clinicians respond, does the intervention fit routine care, and what happens when treatment plans change? For Brisbane and wider Queensland, those practical questions matter as much as the clinical signal, especially for people managing several conditions, limited health literacy or intermittent access to mobile services.

Why Medication Adherence Matters

Medication non-adherence in heart failure can lead to worsening congestion, breathlessness and reduced quality of life, while also increasing avoidable hospital care. The reasons are varied: forgotten doses, side effects, confusion about changes, drug costs, complex routines and difficulty obtaining prescriptions. A text programme should identify these barriers rather than label a missed dose as a lack of motivation.

Australian patients often discuss renewing a “script” and filling it at the “chemist”, while hospitals, Medicare and the Pharmaceutical Benefits Scheme divide treatment and payment across several services. People with heart failure may also have kidney disease, diabetes or COPD, so medication lists can be long and changes made by one clinician may not reach another. A reminder must therefore be accurate and linked to the current treatment plan.

Designing the Text Message Intervention

The intervention can combine scheduled reminders with brief, practical support while participants continue their usual care. Messages can name the medicine and dose when patients consent, ask whether a dose has been taken, offer a simple routine, and provide a route to a pharmacist or heart failure nurse when problems arise. Patients can agree to timing and frequency, stop messages when their regimen changes, and opt out without affecting their care. Texts should never tell someone to change a dose independently.

Plain SMS suits the Australian market because it works on basic phones, does not require mobile data and is commonly included in Australian phone plans, although participants should check their plan. International programmes such as the HARP research consortium offer useful precedents for coordinating research, service design and patient participation when digital health approaches move between health systems. Co-design with patients, carers, nurses and pharmacists should shape message length, language and tone.

A Brisbane and Queensland Study Setting

The Brisbane Diamantina Health Partners network can support a study that connects hospital outpatient services, community pharmacies, universities and primary care. A Brisbane team could recruit through heart failure clinics, GP management-plan reviews and pharmacy services, while Queensland-wide partnerships add rural and remote perspectives. Record recruitment pathways so the team knows which services and patient groups are reached or missed.

Local conditions affect feasibility. Queensland’s hot summers, storms and power interruptions can interrupt phone access or charging, especially for people travelling outside major centres. Connectivity and device access should therefore be asked about respectfully, while an alternative contact method is offered. Cultural safety is equally practical: Aboriginal and Torres Strait Islander communities should shape governance through local health services and community-controlled organisations, with information provided in plain English and with interpreters where needed.

Measures That Test Feasibility

Core measures should include the proportion approached, consented and retained; SMS delivery and response patterns; time spent by clinicians; participant burden; and satisfaction with tone, timing and content. Pharmacy dispensing and patient-reported missed doses can provide complementary adherence signals, although dispensing does not prove that a medicine was taken. Read receipts may not be available on every network, so delivery reports and brief check-ins are more dependable.

Clinical measures such as weight, symptom scores, emergency presentations and admissions can be explored, but a small feasibility cohort cannot establish that texts caused a change. Interviews should ask what triggered missed doses and which messages felt useful, intrusive or confusing. If findings support progression, the next study should prespecify clinical outcomes, comparison groups and sample-size calculations rather than treating promising trends as proof of effectiveness.

Ethics, Safety and Aboriginal Governance

Research governance should cover ethics approval, informed consent, privacy, secure data storage, role-based access and a clear opt-out process under the Privacy Act and applicable Queensland health privacy rules. Participants need to know whether their replies are seen by the research team, the treating service or both. Small incentives, if offered, should not create pressure to continue when someone wants to withdraw.

Medication safety needs clinical ownership. Pharmacists and heart failure teams should verify the starting medication list and define how dose changes are communicated and when messages pause. Participants should not alter treatment because of a text and should use the usual urgent-care pathway for acute symptoms. Aboriginal and Torres Strait Islander data governance should be established with the relevant communities, including authority over interpretation, reporting and any future secondary use of culturally sensitive information.

Recommendations for a Safe Australian Pilot

Training is part of the intervention, not an optional extra. Ward and clinic nurses, community pharmacists and coordinators need consistent scripts, escalation pathways and time to respond. A resource on economic counselling for youth, although outside cardiology, illustrates the value of structured conversations, active listening and clear referral pathways. Training should focus on solving practical barriers without blaming patients.

The following measures provide a practical basis for piloting the programme in Australian health services:

  • Test recruitment, retention, message response and clinician workload before expanding the cohort.
  • Keep the technology accessible through SMS, basic phones and an alternative contact route.
  • Co-design content and workflows with patients, carers, pharmacists and Aboriginal health services.
  • Build consent, opt-out, medication-change and urgent-escalation processes into the workflow.
  • Separate feasibility and adherence findings from exploratory clinical outcomes when deciding on a larger trial.

These measures let the team learn quickly while protecting participants and respecting the demands of busy outpatient and community services.

Moving From Pilot to Practice

The feasibility stage should end with a transparent decision: proceed to a larger trial, revise and test again, or stop if the intervention is not acceptable or safe. Positive anecdotes are insufficient, and favourable adherence results still require scrutiny of burden, equity, confidentiality and staffing. Reporting limitations alongside findings will help other Queensland services judge whether the approach fits their context.

Heart failure teams in Brisbane, Logan and regional Queensland should form a small working group now, bringing together a patient partner, nurse, pharmacist, researcher, privacy lead and Aboriginal health representative. The immediate action is to agree on a co-designed pilot, its feasibility measures and the date for reviewing the evidence. The partnership network can then connect the group with the wider research and clinical expertise needed to deliver it.

Our Partners